GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Elicera Therapeutics ELIC.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.58

-0.77%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Elicera Therapeutics annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
Revenue—SEK 7.1mSEK 11.2mSEK 1.3mSEK 587
Operating income−SEK 17.9m−SEK 16.9m−SEK 28.3m−SEK 19.4m−SEK 13.1m
Net income−SEK 17.4m−SEK 16.1m−SEK 16.4m−SEK 19.5m−SEK 13.1m
Free cash flow−SEK 21.6m−SEK 23.5m−SEK 14.9m−SEK 8.6m−SEK 14.3m
Total assetsSEK 27.4mSEK 27.6mSEK 30.2mSEK 46.3mSEK 54.7m
Shareholders' equitySEK 23.4mSEK 20.8mSEK 16.4mSEK 32.8mSEK 52.2m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.